» Articles » PMID: 24918270

Asbestos-induced Pulmonary Fibrosis is Augmented in 8-oxoguanine DNA Glycosylase Knockout Mice

Abstract

Asbestos causes asbestosis and malignancies by mechanisms that are not fully established. Alveolar epithelial cell (AEC) injury and repair are crucial determinants of the fibrogenic potential of noxious agents such as asbestos. We previously showed that mitochondrial reactive oxygen species mediate asbestos-induced AEC intrinsic apoptosis and that mitochondrial human 8-oxoguanine-DNA glycosylase 1 (OGG1), a DNA repair enzyme, prevents oxidant-induced AEC apoptosis. We reasoned that OGG1 deficiency augments asbestos-induced pulmonary fibrosis. Compared with intratracheal instillation of PBS (50 μl) or titanium dioxide (100 μg/50 μl), crocidolite or Libby amphibole asbestos (100 μg/50 μl) each augmented pulmonary fibrosis in wild-type C57BL/6J (WT) mice after 3 weeks as assessed by histology, fibrosis score, lung collagen via Sircol, and type 1 collagen expression; these effects persisted at 2 months. Compared with WT mice, Ogg1 homozygous knockout (Ogg1(-/-)) mice exhibit increased pulmonary fibrosis after crocidolite exposure and apoptosis in cells at the bronchoalveolar duct junctions as assessed via cleaved caspase-3 immunostaining. AEC involvement was verified by colocalization studies using surfactant protein C. Asbestos increased endoplasmic reticulum stress in the lungs of WT and Ogg1(-/-) mice. Compared with WT, alveolar type 2 cells isolated from Ogg1(-/-) mice have increased mtDNA damage, reduced mitochondrial aconitase expression, and increased P53 and cleaved caspase-9 expression, and these changes were enhanced 3 weeks after crocidolite exposure. These findings suggest an important role for AEC mtDNA integrity maintained by OGG1 in the pathogenesis of pulmonary fibrosis that may represent a novel therapeutic target.

Citing Articles

Therapeutic Approaches for the Treatment of Interstitial Lung Disease: An Exploratory Review on Molecular Mechanisms.

Amin R, Pandey R, Vaishali K, Acharya V, Sinha M, Kumar N Mini Rev Med Chem. 2023; 24(6):618-633.

PMID: 37587813 DOI: 10.2174/1389557523666230816090112.


Mitochondrial quality control in lung diseases: current research and future directions.

Liu J, Wang J, Xiong A, Zhang L, Zhang Y, Liu Y Front Physiol. 2023; 14:1236651.

PMID: 37538379 PMC: 10395103. DOI: 10.3389/fphys.2023.1236651.


Injured Endothelial Cell: A Risk Factor for Pulmonary Fibrosis.

Zhao W, Wang L, Wang Y, Yuan H, Zhao M, Lian H Int J Mol Sci. 2023; 24(10).

PMID: 37240093 PMC: 10218114. DOI: 10.3390/ijms24108749.


Advanced models for respiratory disease and drug studies.

Shrestha J, Paudel K, Nazari H, Dharwal V, Razavi Bazaz S, Johansen M Med Res Rev. 2023; 43(5):1470-1503.

PMID: 37119028 PMC: 10946967. DOI: 10.1002/med.21956.


Promises and Challenges of Cell-Based Therapies to Promote Lung Regeneration in Idiopathic Pulmonary Fibrosis.

Egea-Zorrilla A, Vera L, Saez B, Pardo-Saganta A Cells. 2022; 11(16).

PMID: 36010671 PMC: 9406501. DOI: 10.3390/cells11162595.


References
1.
Karahalil B, Hogue B, de Souza-Pinto N, Bohr V . Base excision repair capacity in mitochondria and nuclei: tissue-specific variations. FASEB J. 2002; 16(14):1895-902. DOI: 10.1096/fj.02-0463com. View

2.
Berger F, Vaslin L, Belin L, Asselain B, Forlani S, Humbert S . The impact of single-nucleotide polymorphisms (SNPs) in OGG1 and XPC on the age at onset of Huntington disease. Mutat Res. 2013; 755(2):115-9. DOI: 10.1016/j.mrgentox.2013.04.020. View

3.
Zheng D, Limmon G, Yin L, Leung N, Yu H, Chow V . A cellular pathway involved in Clara cell to alveolar type II cell differentiation after severe lung injury. PLoS One. 2013; 8(8):e71028. PMC: 3734298. DOI: 10.1371/journal.pone.0071028. View

4.
Mossman B, Lippmann M, Hesterberg T, Kelsey K, Barchowsky A, Bonner J . Pulmonary endpoints (lung carcinomas and asbestosis) following inhalation exposure to asbestos. J Toxicol Environ Health B Crit Rev. 2011; 14(1-4):76-121. PMC: 3118517. DOI: 10.1080/10937404.2011.556047. View

5.
Cardin R, Piciocchi M, Tieppo C, Maddalo G, Zaninotto G, Mescoli C . Oxidative DNA damage in Barrett mucosa: correlation with telomeric dysfunction and p53 mutation. Ann Surg Oncol. 2013; 20 Suppl 3:S583-9. DOI: 10.1245/s10434-013-3043-1. View